Trends of Human Plague, Madagascar, 1998-2016.
Madagascar
Yersinia pestis
bacteria
bubonic plague
case-fatality rate
fleas
human plague
plague
pneumonic plague
rats
trends
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
entrez:
23
1
2019
pubmed:
23
1
2019
medline:
30
7
2019
Statut:
ppublish
Résumé
Madagascar is more seriously affected by plague, a zoonosis caused by Yersinia pestis, than any other country. The Plague National Control Program was established in 1993 and includes human surveillance. During 1998-2016, a total of 13,234 suspected cases were recorded, mainly from the central highlands; 27% were confirmed cases, and 17% were presumptive cases. Patients with bubonic plague (median age 13 years) represented 93% of confirmed and presumptive cases, and patients with pneumonic plague (median age 29 years) represented 7%. Deaths were associated with delay of consultation, pneumonic form, contact with other cases, occurrence after 2009, and not reporting dead rats. A seasonal pattern was observed with recrudescence during September-March. Annual cases peaked in 2004 and decreased to the lowest incidence in 2016. This overall reduction occurred primarily for suspected cases and might be caused by improved adherence to case criteria during widespread implementation of the F1 rapid diagnostic test in 2002.
Identifiants
pubmed: 30666930
doi: 10.3201/eid2502.171974
pmc: PMC6346457
doi:
Substances chimiques
Antigens, Bacterial
0
Types de publication
Historical Article
Journal Article
Langues
eng
Pagination
220-228Références
Parasit Vectors. 2016 Feb 11;9:82
pubmed: 26864070
PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3155
pubmed: 25299064
Vector Borne Zoonotic Dis. 2005 Winter;5(4):305-14
pubmed: 16417426
Science. 2017 Oct 27;358(6362):430-431
pubmed: 29074744
Emerg Infect Dis. 2017 Mar;23(3):521-524
pubmed: 28221119
Lancet. 2000 Jan 8;355(9198):111-3
pubmed: 10675169
Trans R Soc Trop Med Hyg. 2010 Feb;104(2):97-103
pubmed: 19716148
Med Trop (Mars). 1966;26:Suppl 26:79+
pubmed: 6011187
PLoS Negl Trop Dis. 2011 Sep;5(9):e1319
pubmed: 21931876
Emerg Infect Dis. 2007 Oct;13(10):1459-62
pubmed: 18257987
Emerg Infect Dis. 2013 Feb;19(2):230-6
pubmed: 23347743
Emerg Infect Dis. 2017 Sep;23(9):1517-1521
pubmed: 28820134
BMC Pulm Med. 2018 May 29;18(1):92
pubmed: 29843675
Int J Tuberc Lung Dis. 2004 Nov;8(11):1315-20
pubmed: 15581198
Am J Trop Med Hyg. 2014 Jun;90(6):1047-58
pubmed: 24686743
PLoS Negl Trop Dis. 2017 Sep 5;11(9):e0005887
pubmed: 28873412
Wkly Epidemiol Rec. 2006 Jul 14;81(28):278-84
pubmed: 16841399
Microbes Infect. 2000 Jan;2(1):25-31
pubmed: 10717537
Lancet. 1995 Apr 15;345(8955):983-4
pubmed: 7715310
Nat Med. 1995 Dec;1(12):1237-9
pubmed: 7489395
PLoS Negl Trop Dis. 2013 Nov 07;7(11):e2382
pubmed: 24244760
N Engl J Med. 1997 Sep 4;337(10):677-80
pubmed: 9278464
PLoS Negl Trop Dis. 2016 Feb 04;10(2):e0004414
pubmed: 26844772
Trans R Soc Trop Med Hyg. 2009 May;103(5):455-60
pubmed: 19211117
Acta Trop. 1997 Nov;68(2):215-27
pubmed: 9386796
PLoS Pathog. 2011 Sep;7(9):e1002160
pubmed: 21949648
PLoS One. 2014 Nov 04;9(11):e111998
pubmed: 25369291
Trop Med Int Health. 2006 Aug;11(8):1228-37
pubmed: 16903886
Emerg Infect Dis. 2007 Apr;13(4):664-6
pubmed: 17561574
Wkly Epidemiol Rec. 2016 Feb 26;91(8):89-93
pubmed: 26922822
Emerg Infect Dis. 2002 Mar;8(3):311-6
pubmed: 11927030
Emerg Infect Dis. 2015 Jan;21(1):8-15
pubmed: 25530466
Lancet. 2003 Jan 18;361(9353):211-6
pubmed: 12547544
Emerg Infect Dis. 2011 May;17(5):778-84
pubmed: 21529384
Emerg Infect Dis. 2001 Jan-Feb;7(1):43-8
pubmed: 11266293
Vet Res. 2005 May-Jun;36(3):437-53
pubmed: 15845233
Int J Antimicrob Agents. 2018 Feb;51(2):249-254
pubmed: 29030266
Med Trop (Mars). 2005 Nov;65(6):511-4
pubmed: 16555508